Categoria
Nitrofur-C
Nombres de marca,
Nitrofur-C
Analogos
Nitrofur-C
Marca los nombres de mezcla
No information avaliable
Nitrofur-C
Formula quimica
C8H6N4O5
Nitrofur-C
RX enlace
http://www.rxlist.com/cgi/generic/nitro25m.htm
Nitrofur-C
FDA hoja
Nitrofur-C
MSDS (hoja de seguridad de materiales)
Nitrofur-C
Sintesis de referencia
No hay información disponible
Nitrofur-C
Peso molecular
238.157 g/mol
Nitrofur-C
Punto de fusion
263 oC
Nitrofur-C
H2O Solubilidad
79.5 mg / L
Nitrofur-C
Estado
Solid
Nitrofur-C
LogP
-0.04
Nitrofur-C
Formas de dosificacion
Tableta
Nitrofur-C
Indicacion
Para el tratamiento de la infección del tracto urinario
Nitrofur-C
Farmacologia
Nitrofurantoína, un agente antibacteriano nitrofuranos, está disponible en forma microcristalina y macrocristalinas para tratar las infecciones del tracto urinario causada por muchas bacterias gram-negativas y algunas bacterias gram-positivas.
Nitrofur-C
Absorcion
No hay información disponible
Nitrofur-C
Toxicidad
No hay información disponible
Nitrofur-C
Informacion de Pacientes
Patients should be advised to take Macrobid with food (ideally breakfast and dinner) to further
enhance tolerance and improve drug absorption. Patients should be instructed to complete the full course of therapy;
however, they should be advised to contact their physician if any unusual symptoms occur during therapy.
Patients should be advised not to use antacid preparations containing magnesium trisilicate while
taking Macrobid.
Patients should be counseled that antibacterial drugs including Macrobid should only be used to
treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Macrobid is
prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in
the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full
course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that
bacteria will develop resistance and will not be treatable by Macrobid or other antibacterial drugs in the
future.
Nitrofur-C
Organismos afectados
Gram negativos y algunas bacterias gram positivas